Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of psychopharmacology (Oxford) 2010-04, Vol.24 (4), p.623-624
Hauptverfasser:	Kuloglu, M., Caykoylu, A., Ekinci, O., Bayindirli, D., Vural, G., Deniz, O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic Uptake Inhibitors - therapeutic use Adult and adolescent clinical studies Antidepressive Agents, Second-Generation - adverse effects Biological and medical sciences Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Depression Depressive Disorder, Major - diagnosis Depressive Disorder, Major - drug therapy Humans Male Medical sciences Middle Aged Mood disorders Morpholines - therapeutic use Neurology Neuropharmacology Organic mental disorders. Neuropsychology Parkinson Disease, Secondary - chemically induced Paroxetine - adverse effects Pharmacology. Drug treatments Psychiatric Status Rating Scales Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Serotonin Uptake Inhibitors - adverse effects Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!